Orexigen Therapeutics Incorporated (OREX) Stock Quote
Get the latest OREX - Orexigen Therapeutics Incorporated stock market performance data and financial news.
Orexigen Therapeutics Incorporated (OREX) Community Sentiment ...
Get the latest OREX - Orexigen Therapeutics Incorporated together with stock market performance data and financial news.
Jim Cramer's Take on Orexigen Therapeutics Incorporated
Read Jim Cramer's take on Orexigen Therapeutics Incorporated (OREX) and get his latest thoughts on the company?s performance and outlook
Financial Portfolio on Recent Stock Quotes & Stock Market Picks ...
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
Insiders Sell $6M Worth of Valmont
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10578800/1/insiders-sell-6m-worth-of-valmont.html
Orexigen Execs Quit on Heels of Obesity Drug Data
The drugmaker is losing three executives and ending two trials weeks before it releases results of a pivotal obesity drug study.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10451643/1/orexigen-execs-quit-on-heels-of-obesity-drug-data.html
Orexigen Tanks After-Hours on Obesity Data
Obesity patients treated with a weight-loss pill from Orexigen Therapeutics lost an average of 20.3 pounds, or 9.3% of their body weight, over one year, according to results from a phase III study released Thursday.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10456854/1/orexigen-obesity-data-shy-of-fda-standard.html
RealMoney.com: Isolyser Is a Microcap With the Right Stuff
... takes time to form. Such was the case with Isolyser (OREX:Nasdaq - news -
commentary - research - analysis). Although the insider ...
Not Too Late to Follow Insiders at Isolyser
Jonathan Moreland is publisher of InsiderInsights.com, a Web site that analyzes insider trading, and a weekly newsletter. He writes a column that appears on this page as part of his business relationship with TheStreet.com.. Check out TheStreet for the latest stock market news and financial investment headli
http://www.thestreet.com/story/10011295/1/not-too-late-to-follow-insiders-at-isolyser.html
Orexigen to Post Obesity Data in Race With Vivus, Arena
Orexigen Therapeutics is expected to release the first phase III data on its experimental weight-loss drug Contrave ahead of a key investor presentation Monday.. Check out TheStreet for the latest stock market news and financial investment headlines.
Connect with TheStreet